KROSNEUTRAL

KROS P/E Ratio Analysis

6.3x

Higher than 0% of Healthcare sector peers

Updated 2556h ago·SEC filings & market data

Key Takeaway

KROS (KROS) has a P/E Ratio of 6.3x as of May 2026.

Sector Performance

0th percentile

KROS

6.3x

Sector Median

28.5x

Sector Avg

35.3x

📊

Deep Analysis

KROS (KROS) has a P/E Ratio of 6.3x as of May 2026.

This places KROS in the 0th percentile of the Healthcare sector, which has a median P/E Ratio of 28.5x and a sector average of 35.3x. KROS's P/E Ratio is 78.0% below the sector median, a significant divergence that warrants closer examination. In context: Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Frequently Asked Questions

What does the P/E Ratio tell investors about KROS?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

How does KROS's P/E Ratio compare to its sector?

KROS's P/E Ratio of 6.3x compares to a Healthcare sector median of 28.5x, placing it in the 0th percentile.

Who are KROS's closest peers by P/E Ratio?

The closest Healthcare peers by P/E Ratio include: ABT (28.5x), CCLD (28.3x), ALGN (29.1x), AZN (27.0x), AMGN (24.7x).

📚

Learn More About P/E Ratio

DCF Valuation: How to Estimate What a Stock Is Actually Worth

Discounted Cash Flow is the most rigorous way to value a company. It's also the most misunderstood. Here's a plain-English walkthrough with a real example.

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.